New Frontiers in the
Treatment and Management of Heart Failure: A Closer Look at the Role
of Emerging Therapies is a two-part webinar series
A continuing medical
education activity sponsored by NAMCP and AAMCN
This webinar series will provide critical updates on the advances in
the management of heart failure
These are archives of live webinars held between May 12, 2021 to May
If you participated in any of the live webinars, you are not
to claim credit from the archive of that webinar.
By clicking on each of the titles, you will be able to participate
in each part.
It is not required that you participate in all three or in order.
These activities are valid from June 1, 2021 to June 1, 2023
series is supported by an educational grant from
Merck Sharp & Dohme Corp.
This activity is intended for healthcare professionals practicing in managed
Instructions for CME/NCPD: Complete the pre-test,
listen to the audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your internet
browser without completing the post test, you will have ONE more opportunity to
complete. A score of 70% must be achieved on the post test to receive continuing
education credits. If you do not pass the post test after two attempts, you will
not be eligible to try again. Once you complete the evaluation form and score
70% or higher on your post test, you will automatically be given your
Heart failure (HF) is a common condition that
affects approximately 5.7 million people in the United States, and the prognosis
for patients with heart failure has traditionally been poor. Projections show
that by 2030, the prevalence of heart failure will increase 46 percent from
recent estimates. HF is the reason for more than 1 million hospitalizations per
year and an estimated $31 billion in costs in the U.S. each year. Fortunately
for patients with HF, new and emerging therapeutic options have improved both
clinical and economic outcomes for these patients and the system.